Real-World Retrospective Study of Clinical and Economic Outcomes Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma Treated with First-Line Systemic Anti-Cancer Therapies in the United States: Results from the IMPACT UC-III Study.

Simple Summary: This study evaluated real-world outcomes of first-line treatments for advanced or metastatic bladder cancer in the US from 2020 to 2023, using de-identified health records from 2820 patients. Treatments included chemotherapy (37%), immunotherapy (39%), and other therapies (24%). Soci...

Full description

Bibliographic Details

Published in:	Current Oncology Vol. 32; no. 7; pp. 384 - 404
Main Authors:	Moon, Helen H., Ike, Chiemeka, Dixon, Ruth W., Crowe, Christopher L., Venkataraman, Malvika, Morris, Valerie, Kearney, Mairead, Tonnu-Mihara, Ivy, Barron, John
Format:	Journal Article
Published:	MDPI Jul2025
Online Access:	View this record in EBSCOhost